Concepedia

Author

Lanping Ma

Shanghai Institute of Materia MedicaORCID

Also Known As

Jingya Li, L Ma, L. Ma, L.Y. Ma, Lan-Ping Ma, Lan-ping Ma, Lanping Ma, Lan‐Ping Ma, Lindeng Ma, Ma, Lanping

220

Publications

1.2K

Citations

21

H-Index

45

Concepts

All Affiliations

Shanghai Institute of Materia MedicaChinese Academy of SciencesNational Center for Drug ScreeningFudan UniversityLanzhou University
LM

About

Lanping Ma is an author at Shanghai Institute of Materia Medica specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

15

540

2

Biochemistry

8

8

298

3

Natural Sciences

7

7

237

4

Engineering

4

4

63

5

Biomolecular Engineering

3

3

49

Lanping Ma

×

27

Publications

947

Citations

20

H-Index

YearCitations

Correction of xeroderma pigmentosum repair defect by basal transcription factor BTF2 (TFIIH).

Anneke J. van Vuuren, Wim Vermeulen, Lanping Ma,

The EMBO Journal

1994

113

Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and β-secretase

Yiping Zhu, Kun Xiao, Lanping Ma,

Bioorganic & Medicinal Chemistry

2009

102

The XPB subunit of repair/transcription factor TFIIH directly interacts with SUG1, a subunit of the 26S proteasome and putative transcription factor

Geert Weeda, Mireille Rossignol, R. A. Fräser,

Nucleic Acids Research

1997

82

Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma

Xuesai Zhang, Qingrou Li, Hui Zhao,

Oncotarget

2017

45

Inhibition of free radical induced oxidative hemolysis of red blood cells by green tea polyphenols

Lanping Ma, Zai‐Qun Liu, Bo Zhou,

Chinese Science Bulletin

2000

42

Antioxidative and free radical scavenging effects of ecdysteroids from<i>Serratula strangulata</i>

Yujun Cai, Jin-Qiu Dai, Jianguo Fang,

Canadian Journal of Physiology and Pharmacology

2002

41

MCL-1 Degradation Mediated by JNK Activation via MEKK1/TAK1-MKK4 Contributes to Anticancer Activity of New Tubulin Inhibitor MT189

Wei Wang, Ying-Qing Wang, Tao Meng,

Molecular Cancer Therapeutics

2014

41

Virtual Screening and Structure-Based Discovery of Indole Acylguanidines as Potent β-secretase (BACE1) Inhibitors

Yiquan Zou, Li Li, Wuyan Chen,

Molecules

2013

35

Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Wei Zhou, Peng Fang, Dongan Yu,

Molecular Cancer Therapeutics

2023

34

Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody–Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function

Rui Jin, Liang Liu, Yun Xing,

Molecular Cancer Therapeutics

2020

32

Page 1